>>> US Gapping down

Gapping down


In reaction to disappointing earnings/guidance:

  • PPHM -18.7%, CASY -4.3%.

Other news:

  • MARA -13.7% (agreed to sell 1 mln shares of common stock for gross proceeds of approximately $5.0 mln in registered direct offering),
  • ACER -8.2% (to offer and sell shares of its common stock),
  • NCS -6.6% (Prices 7.15 mln common stock offering by investment funds associated with Clayton Dubilier & Rice at $19.55/share),
  • OAS -3.6% (Buys 20,300 acres in the Delaware Basin for ~$946 mln, expects to divest non-core Williston Basin acreage up to $500 mln in 2018; Co separately announced that it has commenced an underwritten public offering of 32 mln shares of common stock),
  • NCS -2.9% (announces secondary offering of 7,150,000 shares of common stock by investment funds associated with Clayton Dubilier & Rice),
  • EIX -2.7% (Southern California Edison confirms multiple wind-driven wildfires moving through Southern California are affecting customers and electric service in Southern California Edison's service territory),
  • BPMC -2.6% (commences underwritten public offering of $275 mln in shares of its common stock),
  • UTL -2.1% (to offer 600k shares of common stock pursuant to an effective shelf registration statement),
  • IRM -1.8% (to acquire the US operations of IO Data Centers for $1.315 billion plus up to $60 million based on future performance; commenced an underwritten public offering of 14,500,000 shares of its common stock),
  • ARGX -1.8% (files for $150 mln ADS offering),
  • BLUE -1.7% (commenced an underwritten public offering of $600 million of its common stock),
  • H -1.7% ( indicated lower on block trade pricing).

Analyst comments:

  • CASY -5.2% (downgraded to Mkt Perform from Outperform at Raymond James),
  • EVTC -2.6% (downgraded to Underweight from Neutral at JP Morgan),
  • MGI -2.2% (downgraded to Underweight from Neutral at JP Morgan),
  • PEGI -1.9% (downgraded to Equal-Weight from Overweight at Morgan Stanley),
  • BRG -1.6% (downgraded to Neutral from Buy at Janney).

>>> US Gapping up

Gapping up

In reaction to strong earnings/guidance:

  • IRET +6.1%, KMG +6%, RCMT +5.1% (Guidance), URBN +0.9%, (Sales Update).

M&A news:

  • RPRX +40.5% (to be acquired by Allergan plc (AGN) for $0.67/share in cash),
  • ALV +1.2% (concludes strategic review and prepares for spin-off of its electronics segment). 

Other news:

  • PTI +44.7% (announced positive study results across all three of the company's CF pipeline programs),
  • APTO +6.1% (presents preclinical demonstrating that CG'806, a highly potent pan-FLT3/pan-BTK inhibitor, exerts a profound anti-leukemia effect in human and murine leukemia cell lines harboring FLT-3 ITD mutations),
  • ATNM +5.8% (ticking higher after highlighting data at ASH showing CD33 expression in significant number of multiple myeloma patients supporting the rationale for Actimab-M),
  • PGLC +3.3% (announces bought deal of $6.8 million and concurrently announces private placement ),
  • OSTK +3.1% (continued momentum),
  • BA +1.2% (Boeing raises quarterly dividend 20% to $1.71/share and replaces the existing share repurchase program with a new $18 billion authorization ),
  • AGIO +0.9% (presents new efficacy and safety data from ongoing Phase 1 study evaluating oral ivosidenib (AG-120) in patients with relapsed or refractory acute myeloid leukemia and an isocitrate dehydrogenase-1 mutation),
  • YTEN +0.9% (after closing up 180% higher on Monday),
  • EGLE +0.9% (completes $265 million refinancing; extended the maturities of the outstanding debt of its subsidiaries through 2022),
  • GSK +0.9% (reports new data for priority BCMA asset from its emerging Oncology pipeline; 60% response rate),
  • SND +0.8% (files for $200 mln mixed securities shelf offering and 19,078,415 share offering by holders). 

Analyst comments:

  • COTY +3.9% (upgraded to Buy from Neutral at Citigroup),
  • ATVI +2.4% (upgraded to Buy from Neutral at Goldman),
  • NOC +1.7% (upgraded to Overweight from Neutral at JP Morgan),
  • ZAYO +1.7% (upgraded to Overweight from Equal-Weight at Morgan Stanley),
  • TER +1.5% (upgraded to Buy from Neutral at Goldman),
  • FCX +0.9% (upgraded to Equal-Weight from Underweight at Morgan Stanley),
  • ABT +0.7% (upgraded to Outperform from Market Perform at BMO Capital Markets),
  • CAG +0.7% (upgraded to Neutral from Sell at UBS).

>>> US Early premarket gappers

Early premarket gappers

Gapping up:
PTI +44.7%, APTO +6.1%, IRET +6.1%, KMG +6%, ATNM +5.8%, RCMT +5.1%, PGLC +3.3%, OSTK +3.1%, BA +1.2%, AGIO +0.9%, YTEN +0.9%, EGLE +0.9%, URBN +0.9%, SND +0.8%.

Gapping down:
PPHM -18.7%, MARA -13.7%, ACER -8.2%, CASY -4.3%, OAS -3.6%, NCS -2.9%, EIX -2.7%, BPMC -2.6%, UTL -2.1%, IRM -1.8%, ARGX -1.8%, BLUE -1.7%, H -1.7%.